Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 6,339 shares, a growth of 297.4% from the April 15th total of 1,595 shares. Currently, 0.3% of the shares of the company are sold short. Based on an average daily volume of 39,192 shares, the days-to-cover ratio is currently 0.2 days.
Arcadia Biosciences Price Performance
Shares of Arcadia Biosciences stock traded down $0.11 during trading on Friday, hitting $0.96. The stock had a trading volume of 59,616 shares, compared to its average volume of 32,421. Arcadia Biosciences has a fifty-two week low of $0.89 and a fifty-two week high of $6.71. The business has a fifty day moving average of $1.41 and a two-hundred day moving average of $2.33. The firm has a market cap of $1.97 million, a P/E ratio of -0.56 and a beta of 0.52.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.80) by ($1.31). The business had revenue of $1.10 million during the quarter, compared to analyst estimates of $1.60 million. Arcadia Biosciences had a positive return on equity of 37.36% and a negative net margin of 48.15%.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on RKDA
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.
Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
